Literature DB >> 8660816

Prostaglandin-E2 regulation of tumor necrosis factor receptor release in human monocytic THP-1 cells.

S S Choi1, M Gatanaga, G A Granger, T Gatanaga.   

Abstract

Recent in vitro studies indicate that tumor necrosis factor (TNF) production in human monocytic THP-1 cells is suppressed by action of arachidonic acid metabolite prostaglandin-E2 (PGE2). PGE2 stimulation of human monocytic cell line THP-1 demonstrates that PGE2 not only regulates TNF activity at production levels, but does so through the release of two soluble TNF receptors (BP-55, BP-75) as well. PGE2 can thus exert a regulatory effect on TNF biologic activity by interfering with its ability to reach cell membrane receptors. THP-1 cells were activated with PGE2 for either 2- or 6-hr time periods, and the supernatants subsequently tested by ELISA to quantitate the levels of soluble receptor released. In addition, we examined mechanisms of receptor shedding by investigating the rate of membrane internalization and the role of serine proteases. PGE2-stimulated THP-1 cells showed soluble 55- and 75-kDa TNF receptor release levels which exceeded that of spontaneous release at both 2- and 6-hr activation periods. The numbers of both membrane TNF receptors were significantly upregulated as well in PGE2-activated cells, whereas the levels of 55- and 75-kDa TNF receptor mRNA levels remained unchanged. Thus, PGE2 induces TNF receptor release primarily at posttranscriptional levels. Inhibition of serine proteases with Pefabloc, a phenylmethylsulfonyl fluoride analog, resulted in the inhibition of both spontaneous and PGE2-stimulated release. Treatment of THP-1 cells with N-ethylmaleimide and low-temperature incubation, both known to block membrane internalization, also blocked spontaneous and PGE2-induced release. Internalization and cleavage by protease are therefore critical factors in PGE2-induced release of soluble TNF receptor shedding.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8660816     DOI: 10.1006/cimm.1996.0150

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  5 in total

1.  Modulatory effect of prostaglandins on human monocyte activation for killing of high- and low-virulence strains of Paracoccidioides brasiliensis.

Authors:  A M Soares; S A Calvi; M T Peraçoli; A C Fernandez; L A Dias; A R Dos Anjos
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

2.  Reduced peripheral PGE2 biosynthesis in Plasmodium falciparum malaria occurs through hemozoin-induced suppression of blood mononuclear cell cyclooxygenase-2 gene expression via an interleukin-10-independent mechanism.

Authors:  Christopher C Keller; James B Hittner; Benjamin K Nti; J Brice Weinberg; Peter G Kremsner; Douglas J Perkins
Journal:  Mol Med       Date:  2004 Jan-Jun       Impact factor: 6.354

Review 3.  Regulation of serum amyloid A protein expression during the acute-phase response.

Authors:  L E Jensen; A S Whitehead
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

4.  METEORIN-LIKE is a cytokine associated with barrier tissues and alternatively activated macrophages.

Authors:  Irina Ushach; Amanda M Burkhardt; Cynthia Martinez; Peter A Hevezi; Peter Arne Gerber; Bettina Alexandra Buhren; Holger Schrumpf; Ricardo Valle-Rios; Monica I Vazquez; Bernhard Homey; Albert Zlotnik
Journal:  Clin Immunol       Date:  2014-12-05       Impact factor: 3.969

5.  Hemocompatibility and biocompatibility of antibacterial biomimetic hybrid films.

Authors:  M Carme Coll Ferrer; Uriel N Eckmann; Russell J Composto; David M Eckmann
Journal:  Toxicol Appl Pharmacol       Date:  2013-08-07       Impact factor: 4.219

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.